Pfizer, Moderna, BioNTech trade lower amid report of vaccine link to child deaths
TransUnion (NYSE:TRU) President, US Markets, Steven M. Chaouki, sold 1,000 shares of common stock on September 2, 2025, at a price of $86.12, for a total transaction value of $86,120. The transaction comes as TransUnion , with a market capitalization of $16.8 billion, maintains impressive gross profit margins of 59% and shows strong liquidity with a current ratio of 2.02. According to InvestingPro analysis, the company’s stock currently trades near its Fair Value.
Following the transaction, Chaouki directly owns 65,592 shares of TransUnion. The sale was executed under a pre-arranged Rule 10b5-1 trading plan. InvestingPro analysis reveals 8+ additional key insights about TransUnion’s financial health and market position, available exclusively to subscribers through detailed Pro Research Reports covering 1,400+ top US stocks.
In other recent news, TransUnion has reported quarterly results that exceeded both consensus estimates and the company’s own guidance, showcasing stable lending volumes throughout the period. This positive performance has led BMO Capital to raise its price target for TransUnion to $118, maintaining an Outperform rating. Similarly, Stifel increased its price target from $112 to $127, citing the company’s internal efforts and slightly improved market conditions, while keeping a Buy rating. Needham has also upgraded TransUnion from Hold to Buy, highlighting the company’s momentum with fintech clients and improving conditions in India. RBC Capital reiterated an Outperform rating, pointing out the potential for TransUnion to exceed its fiscal year 2025 guidance. Additionally, TransUnion’s Board of Directors declared a quarterly cash dividend of $0.115 per share, payable on September 8, 2025, to shareholders of record as of August 22, 2025. These developments reflect a positive outlook from analysts and continued investor interest in TransUnion.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.